failure and liver cancer. at novo nordisk, we have committed significant resources in research and development to improve the lives of people living with nash, for whom no therapeutic offerings exist today. explore nash haemophilia around 450,000 people worldwide live with haemophilia6,7, a serious...
failure and liver cancer. at novo nordisk, we have committed significant resources in research and development to improve the lives of people living with nash, for whom no therapeutic offerings exist today. explore nash haemophilia around 450,000 people worldwide live with haemophilia6,7, a serious...